Abbott's MDx Sales Rise 14 Percent in Q1

The company expects to launch more than a dozen new molecular diagnostic products over the next two to three years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories